AIM: This paper is a report of a study conducted to characterize the stigma of urinary frequency and urgency and differentiate it from the stigma of incontinence and to describe race/ethnic and gender differences in the experience of stigma among a diverse sample of individuals. BACKGROUND: Lower urinary tract symptoms, including frequency, urgency and incontinence, are susceptible to stigma, but previous stigma research has focused almost exclusively on incontinence. METHOD: The Boston Area Community Health Survey is a population-based, random sample epidemiological survey of urologic symptoms (N = 5503). Qualitative data for this study came from in-depth interviews conducted between 2007 and 2008 with a random subsample of 151 black, white and Hispanic men and women with urinary symptoms. FINDINGS: Respondents reported stigma associated with frequency and urgency - not just incontinence. The stigma of frequency/urgency is rooted in social interruption, loss of control of the body, and speculation as to the nature of a non-specific 'problem'. Overall, the stigma of urinary symptoms hinged upon whether or not the problem was 'perceptible'. Men felt stigmatized for making frequent trips to the bathroom and feared being seen as impotent. Women feared having an unclean body or compromised social identity. Hispanic people in particular voiced a desire to keep their urinary symptoms a secret. CONCLUSION: The stigma of urinary symptoms goes beyond incontinence to include behaviours associated with frequency and urgency. Healthcare practitioners should assess for stigma sequelae (e.g. anxiety, depression) in individuals with frequency and urgency, and stress treatment options to circumvent stigmatization.
AIM: This paper is a report of a study conducted to characterize the stigma of urinary frequency and urgency and differentiate it from the stigma of incontinence and to describe race/ethnic and gender differences in the experience of stigma among a diverse sample of individuals. BACKGROUND: Lower urinary tract symptoms, including frequency, urgency and incontinence, are susceptible to stigma, but previous stigma research has focused almost exclusively on incontinence. METHOD: The Boston Area Community Health Survey is a population-based, random sample epidemiological survey of urologic symptoms (N = 5503). Qualitative data for this study came from in-depth interviews conducted between 2007 and 2008 with a random subsample of 151 black, white and Hispanic men and women with urinary symptoms. FINDINGS: Respondents reported stigma associated with frequency and urgency - not just incontinence. The stigma of frequency/urgency is rooted in social interruption, loss of control of the body, and speculation as to the nature of a non-specific 'problem'. Overall, the stigma of urinary symptoms hinged upon whether or not the problem was 'perceptible'. Men felt stigmatized for making frequent trips to the bathroom and feared being seen as impotent. Women feared having an unclean body or compromised social identity. Hispanic people in particular voiced a desire to keep their urinary symptoms a secret. CONCLUSION: The stigma of urinary symptoms goes beyond incontinence to include behaviours associated with frequency and urgency. Healthcare practitioners should assess for stigma sequelae (e.g. anxiety, depression) in individuals with frequency and urgency, and stress treatment options to circumvent stigmatization.
Authors: William L Holzemer; Sarie Human; John Arudo; María E Rosa; Mary Jane Hamilton; Inge Corless; Linda Robinson; Patrice K Nicholas; Dean J Wantland; Shahnaz Moezzi; Suzanne Willard; Kenn Kirksey; Carmen Portillo; Elizabeth Sefcik; Marta Rivero-Méndez; Mary Maryland Journal: J Assoc Nurses AIDS Care Date: 2009 May-Jun Impact factor: 1.354
Authors: Karin S Coyne; Louis S Matza; Zoe S Kopp; Christine Thompson; David Henry; Debra E Irwin; Walter Artibani; Sender Herschorn; Ian Milsom Journal: BJU Int Date: 2008-03-11 Impact factor: 5.588
Authors: Amy Cinar; Susan A Hall; Carol L Link; Steven A Kaplan; Zoe S Kopp; Claus G Roehrborn; Raymond C Rosen Journal: BJU Int Date: 2008-05 Impact factor: 5.588
Authors: Karin S Coyne; Alan J Wein; Andrea Tubaro; Chris C Sexton; Christine L Thompson; Zoe S Kopp; Lalitha P Aiyer Journal: BJU Int Date: 2009-04 Impact factor: 5.588
Authors: Susan A Hall; Nancy N Maserejian; Carol L Link; William D Steers; John B McKinlay Journal: Eur J Clin Pharmacol Date: 2011-12-04 Impact factor: 2.953
Authors: Sonya S Brady; Tamara G Bavendam; Amanda Berry; Cynthia S Fok; Sheila Gahagan; Patricia S Goode; Cecilia T Hardacker; Jeni Hebert-Beirne; Cora E Lewis; Jessica B Lewis; Lisa Kane Low; Jerry L Lowder; Mary H Palmer; Jean F Wyman; Emily S Lukacz Journal: Neurourol Urodyn Date: 2018-08-22 Impact factor: 2.696
Authors: Amy Y Zhang; Alex Z Fu; Shirley Moore; Hui Zhu; Gerald Strauss; Denise Kresevic; Eric Klein; Lee Ponsky; Donald R Bodner Journal: J Cancer Surviv Date: 2016-06-24 Impact factor: 4.442